Literature DB >> 31587917

Cost and Mortality Analysis of an Intermediate Respiratory Care Unit. Is It Really Efficient and Safe?

Sarah Heili-Frades1, María Del Pilar Carballosa de Miguel2, Alba Naya Prieto2, Marina Galdeano Lozano3, Xavier Mate García4, Ignacio Mahillo Fernández5, Itziar Fernández Ormaechea2, Laura Álvarez Suárez2, Farah Ezzine de Blas2, María José Checa Venegas2, Nicolás González Mangado2, Germán Peces Barba2.   

Abstract

INTRODUCTION: Historically, it has been assumed that Intermediate Respiratory Care Units (IRCU) were efficient, because they saved costs by reducing the number of admissions to intensive care units (ICU), and effective, because they specialized in respiratory diseases.
METHODS: The number of IRCU admissions and mortality rate, historically and in 2016, were evaluated. For 2016, the grouped Related Diagnostic Groups (DRGs) were also described, and the savings achieved under all budgetary headings by avoiding UCI stays were calculated. A multivariate analysis was performed to associate costs with mean weights and complexity, and multiple logistic regression was performed on all patients admitted from 2004 to 2017 to describe the variables associated with mortality in our unit.
RESULTS: An IRCU generates savings of €500,000/year by reducing length of ICU stay. Analysis of the 2016 cohort shows that costs correlate with mean weight and mortality, and consequently complexity. The multivariate logistic regression analysis of the 2004-2017 cohort found respiratory frequency, leukopenia, anemia, hyperkalemia, and acidosis to be the variables best associated with mortality. The area under the curve for the logistic model was 0.75.
CONCLUSION: The IRCU analyzed in our study was efficient in terms of 'avoided costs' and savings associated with complexity. Our results suggest that IRCUs have a lower mortality rate than other similar units, and are therefore a safe environment for patients.
Copyright © 2019 SEPAR. Publicado por Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Cost; Coste; Efficacy; Efficiency; Eficacia; Eficiencia; Intermediate Respiratory Care Unit; Safety; Seguridad; Unidad de cuidados intermedios respiratorios

Mesh:

Year:  2019        PMID: 31587917     DOI: 10.1016/j.arbres.2019.06.008

Source DB:  PubMed          Journal:  Arch Bronconeumol (Engl Ed)        ISSN: 0300-2896            Impact factor:   4.872


  3 in total

1.  Effectiveness of Intermediate Respiratory Care Units as an Alternative to Intensive Care Units during the COVID-19 Pandemic in Catalonia.

Authors:  Marina Galdeano Lozano; Julio César Alfaro Álvarez; Núria Parra Macías; Rosario Salas Campos; Sarah Heili Frades; Josep Maria Montserrat; Antoni Rosell Gratacós; Jorge Abad Capa; Olga Parra Ordaz; Francesc López Seguí
Journal:  Int J Environ Res Public Health       Date:  2022-05-16       Impact factor: 4.614

2.  The border territories of the specialty.

Authors:  Pere Casan Clarà; Francisco Rodríguez Jerez; Cristina Martínez González
Journal:  Arch Bronconeumol       Date:  2021-07-02       Impact factor: 6.333

3.  Clinical Outcomes of Severe COVID-19 Patients Admitted to an Intermediate Respiratory Care Unit.

Authors:  Guillermo Suarez-Cuartin; Merce Gasa; Guadalupe Bermudo; Yolanda Ruiz; Marta Hernandez-Argudo; Alfredo Marin; Pere Trias-Sabria; Ana Cordoba; Ester Cuevas; Mikel Sarasate; Albert Ariza; Joan Sabater; Nuria Romero; Cristina Subirana; Maria Molina-Molina; Salud Santos
Journal:  Front Med (Lausanne)       Date:  2021-07-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.